Search Results 1-10 of 5036 for Wegovy

1. Mayo Clinic Minute: Weight-loss medications alone are not a quick fix

   Medications called semaglutides — better known by the brand names Ozempic and Wegovy — have been shown to help people lose about 15% of their body weight.

2. Semaglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Kidney disease or; Pancreatitis (inflammation of the pancreas), history of or; Type 2 diabetes (for patients using Wegovy®)—Use with caution. May make ...

3. Diabetes drugs and weight loss - Mayo Clinic

   There are two main groups of type 2 diabetes medicines that lower blood sugar and also may lead to weight loss. The first group is glucagon-like peptide 1 ...

4. Semaglutide (oral route) - Side effects & dosage - Mayo Clinic

   Brand Name. US Brand Name. Rybelsus. Wegovy. Back to top. Description ... For oral dosage form (Wegovy® tablets):. Adults—At first, 1.5 milligrams (mg) ...

5. Mayo Clinic Minute: Weaning off popular weight-loss medications

   Many people have lost unwanted pounds by using popular injectable weight-loss medications such as Ozempic, Wegovy and Zepbound.

6. Prescription weight-loss drugs - Mayo Clinic

   Bupropion-naltrexone (Contrave). Liraglutide (Saxenda). Orlistat (Xenical). Phentermine-topiramate (Qsymia). Semaglutide (Wegovy). Tirzepatide (Zepbound) ...

7. Mayo Clinic Minute: What's the skinny on weight-loss drugs?

   It's a medication called semaglutide — better known by the brand names Ozempic and Wegovy. Ozempic is approved by the Food and Drug Administration to treat Type ...

8. A Study to Evaluate How Semaglutide Works Compared to Placebo in People with Type 2 Diabetes and Chronic Kidney Disease - Mayo Clinic

   The purpose of this study is to evaluate whether or not semaglutide can slow down the growth and worsening of chronic kidney disease in people with type 2 ...

9. Use of weight-loss pharmacotherapy in patients with cirrhosis and in liver transplant recipients - Mayo Clinic

   Dr. Watt is a hepatologist at Mayo Clinic in Rochester, Minnesota, and serves as medical director for liver transplantation at the William J. von Liebig Center ...

10. Genetic test predicts response to weight-loss drugs - Mayo Clinic News Network

    The team has conducted additional studies to predict response to semaglutide, another GLP-1 medication (sold under the brand names Ozempic and Wegovy), and ...